Novo CEO pressed by Senate to cut charges of being overweight, diabetic issues medicines CEO Lars Fruergaard Jørgensen instructed lawmakers the organization would think about new talks with insurers about the record price ranges of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. https://daltonvjida.theideasblog.com/31082795/5-easy-facts-about-healthcare-news-described